ofloxacin has been researched along with Campylobacter Infection in 16 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The recommended treatment for traveler's diarrhea is the combination of an appropriate antibiotic (usually a fluoroquinolone) and loperamide." | 9.12 | Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. ( Frenck, RW; Johnston, JR; Monteville, MR; Putnam, SD; Riddle, MS; Rockabrand, DM; Sanders, JW; Tribble, DR; Ulukan, S, 2007) |
| "The clinical efficacy, safety and usefulness of Rokitamycin (RKM), a new macrolide antibiotic, were compared with those of Ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double blind method." | 9.07 | [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis]. ( Machii, A; Nitta, Y; Obana, M; Ota, S; Sagara, H; Sato, J; Seo, T; Takizawa, Y; Tomizawa, I; Tsunoda, T, 1991) |
| " The therapeutic combination of H2-receptor-antagonists (= H2-RA) and ofloxacin (Tarivid) has shown to heal resistant duodenal ulcers in some preliminary cases, which did not respond to a three month standard dosage treatment with H2-RA." | 5.27 | [Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study]. ( Bayerdörffer, E; Kasper, G; Ottenjann, R; Pirlet, T; Sommer, A, 1988) |
| "The recommended treatment for traveler's diarrhea is the combination of an appropriate antibiotic (usually a fluoroquinolone) and loperamide." | 5.12 | Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. ( Frenck, RW; Johnston, JR; Monteville, MR; Putnam, SD; Riddle, MS; Rockabrand, DM; Sanders, JW; Tribble, DR; Ulukan, S, 2007) |
| "The clinical efficacy, safety and usefulness of Rokitamycin (RKM), a new macrolide antibiotic, were compared with those of Ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double blind method." | 5.07 | [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis]. ( Machii, A; Nitta, Y; Obana, M; Ota, S; Sagara, H; Sato, J; Seo, T; Takizawa, Y; Tomizawa, I; Tsunoda, T, 1991) |
| "Levofloxacin's efficacy was inferior to azithromycin's efficacy, except in patients with no pathogen identified during the first 24 h of treatment or in patients with levofloxacin-susceptible Campylobacter isolates, in whom it appeared to be equal to azithromycin." | 2.73 | Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. ( Armstrong, A; Baqar, S; Bodhidatta, L; Faix, DJ; Fox, A; Hshieh, P; Lawler, JV; Lebron, C; Lewis, M; Maley, EA; Mason, C; Nayak, G; Pang, LW; Pitarangsi, C; Sanders, JW; Scott, DA; Tribble, DR, 2007) |
| "Its efficacy for the treatment of human campylobacteriosis should be evaluated in clinical trials." | 1.36 | Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. ( Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A, 2010) |
| " The therapeutic combination of H2-receptor-antagonists (= H2-RA) and ofloxacin (Tarivid) has shown to heal resistant duodenal ulcers in some preliminary cases, which did not respond to a three month standard dosage treatment with H2-RA." | 1.27 | [Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study]. ( Bayerdörffer, E; Kasper, G; Ottenjann, R; Pirlet, T; Sommer, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehtopolku, M | 1 |
| Nakari, UM | 1 |
| Kotilainen, P | 1 |
| Huovinen, P | 1 |
| Siitonen, A | 1 |
| Hakanen, AJ | 1 |
| Kuuliala, A | 1 |
| Julkunen, H | 1 |
| Paimela, L | 1 |
| Peltomaa, R | 1 |
| Kautiainen, H | 1 |
| Repo, H | 1 |
| Leirisalo-Repo, M | 1 |
| Sanders, JW | 2 |
| Frenck, RW | 1 |
| Putnam, SD | 1 |
| Riddle, MS | 1 |
| Johnston, JR | 1 |
| Ulukan, S | 1 |
| Rockabrand, DM | 1 |
| Monteville, MR | 1 |
| Tribble, DR | 2 |
| Aggarwal, H | 1 |
| Kushnir, L | 1 |
| Conti, D | 1 |
| Gallichio, M | 1 |
| Tobin, E | 1 |
| Pang, LW | 1 |
| Mason, C | 1 |
| Pitarangsi, C | 1 |
| Baqar, S | 1 |
| Armstrong, A | 1 |
| Hshieh, P | 1 |
| Fox, A | 1 |
| Maley, EA | 1 |
| Lebron, C | 1 |
| Faix, DJ | 1 |
| Lawler, JV | 1 |
| Nayak, G | 1 |
| Lewis, M | 1 |
| Bodhidatta, L | 1 |
| Scott, DA | 1 |
| DuPont, HL | 1 |
| Saito, M | 1 |
| Seo, T | 2 |
| Matsubara, Y | 1 |
| Tomizawa, I | 2 |
| Takizawa, Y | 2 |
| Ito, K | 1 |
| Konishi, K | 1 |
| Matsunaga, M | 1 |
| Yanagishita, T | 1 |
| Kosugi, M | 1 |
| Landau, Z | 1 |
| Agmon, NL | 1 |
| Argas, D | 1 |
| Arcavi, L | 1 |
| Simon, D | 1 |
| Miskin, A | 1 |
| Schwartz, D | 1 |
| Goossens, H | 1 |
| Levy, J | 1 |
| Butzler, JP | 1 |
| Goldhar, J | 1 |
| Chuma, T | 1 |
| Ikeda, T | 1 |
| Maeda, T | 1 |
| Niwa, H | 1 |
| Okamoto, K | 1 |
| Obana, M | 1 |
| Nitta, Y | 1 |
| Sagara, H | 1 |
| Sato, J | 1 |
| Tsunoda, T | 1 |
| Ota, S | 1 |
| Machii, A | 1 |
| Zelenková, J | 1 |
| Toman, R | 1 |
| Bielaszewská, M | 1 |
| Hanika, J | 1 |
| Zeman, V | 1 |
| Glupczynski, Y | 1 |
| Labbe, M | 1 |
| Burette, A | 1 |
| Delmee, M | 1 |
| Avesani, V | 1 |
| Bruck, C | 1 |
| Bayerdörffer, E | 3 |
| Simon, T | 1 |
| Bästlein, C | 1 |
| Ottenjann, R | 3 |
| Kasper, G | 3 |
| Pirlet, T | 2 |
| Sommer, A | 2 |
1 review available for ofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Acute cholecystitis caused by Campylobacter jejuni.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Infective Agents; Campylobacter Infections; Campylobact | 1995 |
8 trials available for ofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Reactive; Campylobacter Infections; Chlamydia Infections; D | 2013 |
Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.
Topics: Adult; Azithromycin; Campylobacter Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combinat | 2007 |
Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Communit | 2007 |
[Comparison of clinical efficacy of ofloxacin COFLX: DL-8280) and pipemidic acid (PPA) in acute infectious diarrhea by a double-blind method. The Japan Research Committee of Ofloxacin, Research Group for Acute Infectious Diarrhea].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Campylobacter I | 1984 |
[Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis].
Topics: Adolescent; Adult; Aged; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Double- | 1991 |
Treatment failure of ofloxacin in Campylobacter pylori infection.
Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Clinical Trials as Topic; Double-Bli | 1987 |
Bismuth/ofloxacin combination for duodenal ulcer.
Topics: Anti-Infective Agents; Bismuth; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Co | 1987 |
[Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].
Topics: Adult; Aged; Aged, 80 and over; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Co | 1987 |
7 other studies available for ofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapene | 2010 |
A case of Campylobacter jejuni bacteremia in a renal transplant patient.
Topics: Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Diarrhea; Female; | 2010 |
Azithromycin for the self-treatment of traveler's diarrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Community-Acqui | 2007 |
Plasmid profiles and antimicrobial susceptibility of Campylobacter jejuni isolated from Israeli children with diarrhea.
Topics: Amoxicillin; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Ciproflox | 1993 |
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter | 2001 |
[Campylobacter pylori and treatment of duodenal ulcer].
Topics: Adult; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Female; Gastritis; Humans; Male; Mid | 1990 |
[Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study].
Topics: Adult; Aged; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Duodeno | 1988 |